Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of THNSL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 98% | 3127.22 | 640 / 653 | 96% | 26.99 | 578 / 605 |
kidney | 100% | 2820.66 | 89 / 89 | 92% | 23.81 | 831 / 901 |
prostate | 98% | 3080.56 | 241 / 245 | 94% | 23.06 | 471 / 502 |
liver | 99% | 3108.45 | 223 / 226 | 92% | 17.80 | 373 / 406 |
breast | 96% | 2098.44 | 442 / 459 | 94% | 24.17 | 1048 / 1118 |
ovary | 93% | 2043.95 | 167 / 180 | 87% | 12.45 | 376 / 430 |
pancreas | 91% | 994.20 | 297 / 328 | 88% | 11.40 | 156 / 178 |
skin | 83% | 1026.24 | 1494 / 1809 | 85% | 17.55 | 399 / 472 |
adrenal gland | 93% | 2883.61 | 240 / 258 | 74% | 10.70 | 170 / 230 |
lung | 86% | 1091.80 | 496 / 578 | 78% | 12.90 | 906 / 1155 |
intestine | 96% | 2113.63 | 924 / 966 | 68% | 8.22 | 360 / 527 |
uterus | 92% | 1696.28 | 156 / 170 | 65% | 8.37 | 299 / 459 |
bladder | 90% | 1865.86 | 19 / 21 | 66% | 8.43 | 331 / 504 |
stomach | 92% | 1455.40 | 329 / 359 | 55% | 6.23 | 157 / 286 |
esophagus | 90% | 1719.59 | 1300 / 1445 | 54% | 6.49 | 99 / 183 |
brain | 84% | 1084.18 | 2209 / 2642 | 38% | 4.30 | 270 / 705 |
muscle | 99% | 4195.51 | 796 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 24.89 | 78 / 80 |
adipose | 93% | 1397.59 | 1120 / 1204 | 0% | 0 | 0 / 0 |
heart | 90% | 1421.96 | 779 / 861 | 0% | 0 | 0 / 0 |
spleen | 89% | 1022.15 | 214 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 82% | 831.70 | 1089 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 4.39 | 22 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 2.47 | 8 / 29 |
peripheral blood | 4% | 18.79 | 33 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009071 | Biological process | serine family amino acid catabolic process |
GO_0007165 | Biological process | signal transduction |
GO_0046360 | Biological process | 2-oxobutyrate biosynthetic process |
GO_0008150 | Biological process | biological_process |
GO_0016311 | Biological process | dephosphorylation |
GO_0005575 | Cellular component | cellular_component |
GO_0005615 | Cellular component | extracellular space |
GO_0070905 | Molecular function | serine binding |
GO_0004795 | Molecular function | threonine synthase activity |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | THNSL2 |
Protein name | Threonine synthase-like 2 (TSH2) (EC 4.2.3.-) (Secreted osteoclastogenic factor of activated T-cells) (SOFAT) Threonine synthase like 2 Threonine synthase like 2 (cDNA FLJ76990) (cDNA, FLJ79480) |
Synonyms | |
Description | FUNCTION: [Isoform 1]: Acts as a catabolic phospho-lyase on both gamma- and beta-phosphorylated substrates. Degrades O-phospho-threonine (PThr) to alpha-ketobutyrate, ammonia and phosphate (By similarity). .; FUNCTION: [Isoform SOFAT]: Potent inducer of osteoblastic production of IL6. May act to exacerbate inflammation and/or bone turnover under inflammatory conditions. . |
Accessions | C9J3J1 ENST00000324166.7 [Q86YJ6-1] ENST00000496844.6 [Q86YJ6-3] ENST00000419759.5 ENST00000674334.2 [Q86YJ6-1] ENST00000449349.5 ENST00000343544.8 [Q86YJ6-2] A8K0C1 Q86YJ6 ENST00000377254.7 C9JU10 |